Literature DB >> 17867720

The need for definitions in pharmacovigilance.

Marie Lindquist1.   

Abstract

Mesh：

Year:  2007        PMID： 17867720     DOI： 10.2165/00002018-200730100-00001

Source DB:  PubMed          Journal:  Drug Saf        ISSN： 0114-5916            Impact factor:   5.606


× No keyword cloud information.
  1 in total

Review 1.  Harmonisation in pharmacovigilance.

Authors:  I R Edwards; C Biriell
Journal:  Drug Saf       Date:  1994-02       Impact factor: 5.606
  1 in total
  13 in total

1.  A Multiagent System for Integrated Detection of Pharmacovigilance Signals.

Authors:  Vassilis Koutkias; Marie-Christine Jaulent
Journal:  J Med Syst       Date:  2015-11-21       Impact factor: 4.460

2.  Understanding and communicating key concepts in risk management: what do we mean by benefit and risk?

Authors:  I Ralph Edwards; Marie Lindquist
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

Review 3.  Defining 'signal' and its subtypes in pharmacovigilance based on a systematic review of previous definitions.

Authors:  Manfred Hauben; Jeffrey K Aronson
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

4.  Hybrid Semantic Analysis for Mapping Adverse Drug Reaction Mentions in Tweets to Medical Terminology.

Authors:  Ehsan Emadzadeh; Abeed Sarker; Azadeh Nikfarjam; Graciela Gonzalez
Journal:  AMIA Annu Symp Proc       Date:  2018-04-16

5.  Harms in Systematic Reviews Paper 1: An introduction to research on harms.

Authors:  Riaz Qureshi; Evan Mayo-Wilson; Tianjing Li
Journal:  J Clin Epidemiol       Date:  2021-11-03       Impact factor: 7.407

6.  Self-medication in older urban mexicans : an observational, descriptive, cross-sectional study.

Authors:  Fernando Ruiz Balbuena; Alfredo Briones Aranda; Albert Figueras
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

7.  Pharmacovigilance on twitter? Mining tweets for adverse drug reactions.

Authors:  Karen O'Connor; Pranoti Pimpalkhute; Azadeh Nikfarjam; Rachel Ginn; Karen L Smith; Graciela Gonzalez
Journal:  AMIA Annu Symp Proc       Date:  2014-11-14

Review 8.  Data mining of the public version of the FDA Adverse Event Reporting System.

Authors:  Toshiyuki Sakaeda; Akiko Tamon; Kaori Kadoyama; Yasushi Okuno
Journal:  Int J Med Sci       Date:  2013-04-25       Impact factor: 3.738

9.  Awareness among nurses about reporting of adverse drug reactions in Sweden.

Authors:  Elisabet Ekman; Göran Petersson; Sven Tågerud; Martin Bäckström
Journal:  Drug Healthc Patient Saf       Date:  2012-06-28

10.  Pharmacovigilance workflow in Europe and Italy and pharmacovigilance terminology.

Authors:  Paolo Baldo; Sara Francescon; Giulia Fornasier
Journal:  Int J Clin Pharm       Date:  2018-08-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.